Vascularized composite allografts and solid organ transplants: Similarities and differences

Current Opinion in Organ Transplantation

Volumn 18, Issue 6, 2013, Pages 640-644

  Weissenbacher, Annemarie ^a   Hautz, Theresa ^a   Pratschke, Johann ^a   Schneeberger, Stefan ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Bone marrow transplantation; Immune biology; Immunosuppression; Rejection; Vascularized composite allotransplantation

Indexed keywords

ALEMTUZUMAB; ALLOANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; CLOBETASOL; CLOBETASOL PROPIONATE; CREATININE; CYCLOPHOSPHAMIDE; FLUDARABINE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIMECROLIMUS; RAPAMYCIN; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHIMERA; CHRONIC GRAFT REJECTION; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED CANCER; FACIAL TRANSPLANTATION; FOREARM TRANSPLANTATION; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HAND TRANSPLANTATION; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HINDLIMB; HLA MATCHING; HUMAN; HYPERGLYCEMIA; HYPERPLASIA; HYPERURICEMIA; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; INFECTIOUS COMPLICATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIVING DONOR; LONG TERM SURVIVAL; LUNG TRANSPLANTATION; MAINTENANCE THERAPY; MEMORY T LYMPHOCYTE; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLIC DISORDER; MONOTHERAPY; NEPHROTOXICITY; NONHUMAN; NONMYELOABLATIVE CONDITIONING; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; REVIEW; SIDE EFFECT; SKIN BIOPSY; SKIN CANCER; SKIN DISEASE; SYSTEMIC THERAPY; TRANSPLANTATION TOLERANCE; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION; WHOLE BODY RADIATION; WOUND INFECTION;

CLINICAL TRIALS AS TOPIC; GRAFT REJECTION; HUMANS; IMMUNOMODULATION; IMMUNOSUPPRESSION; ORGAN TRANSPLANTATION; RESOURCE ALLOCATION; TRANSPLANTATION TOLERANCE; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION;

EID: 84888301641     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000019     Document Type: Review

References (54)

1. Sayegh MH, Carpenter CB. Transplantation 50 years later - progress, challenges, and promises. N Engl J Med 2004; 351:2761-2766.
2. Morris PJ. Transplantation - a medical miracle of the 20th century. N Engl J Med 2004; 351:2678-2680.
3. Nankivell BJ, Alexander SI. Rejection of the kidney allograft. N Engl J Med 2010; 363:1451-1462.
4. Solez K. History of the Banff classification of allograft pathology as it approaches its 20th year. Curr Opin Organ Transplant 2010; 15:49-51.
5. Merrill JP, Murray JE, Harrison JH, Guild WR. Successful homotransplantations of the human kidney between identical twins. J Am Med Assoc 1956; 160:277-282.
6. Murray JE. Organ transplantation (skin, kidney, heart) and the plastic surgeon. 1971; 47:425-431.
7. Kino T, Hatanaka H, Miyata S, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot 1987; 40:1256-1265.
8. Calne RY. The rejection of renal homografts. Inhibition in dogs by 6-mercaptopurine. Lancet 1960; 1:417-418.
9. Zukoski CF, Lee HM, Hume DM. The prolongation of functional survival of canine renal homografts by 6-mercaptopurine. Surg Forum 1960; 11:470-472.
10. Hautz T, Brandacher G, Engelhardt TO, et al. How reconstructive transplantation is different from organ transplantation - and how it is not. Transplant Proc 2011; 43:3504-3511.
11. Gilbert R. Hand transplanted from cadaver is reamputated. Med Trib Med News 1964; 5:23.
12. Dubernard JM, Owen E, Herzberg G, et al. Human hand allograft: report on first 6 months. Lancet 1999; 353:1315-1320.
13. Lanzetta M, Petruzzo P, Dubernard JM, et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation 2010; 90:1590-1594.
14. Bradbury E. The psychological and social impact of disfigurement to the hand in children and adolescents. Dev Neurorehabil 2007; 10:143-148.
15. Gander B, Brown CS, Vasilic D, et al. Composite tissue allotransplantation of the hand and face: a new frontier in transplant and reconstructive surgery. Transpl Int 2006; 19:868-880.
16. Hettiaratchy S, Buttler PE. Extending the boundaries of transplantation. BMJ 2003; 326:1226-1227.
17. Kumnig M, Jowsey SG, Rumpold G, et al. The psychological assessment of candidates for reconstructive hand transplantation. Transpl Int 2012; 25:573-585.
18. Bonastre J, Landin L, Diez J, et al. Factors influencing acute rejection of human hand allografts: a systematic review. Ann Plast Surg 2012; 68:624-629.
19. Schneeberger S, Morelon E, Landin L, ESOT CTA Committee. Vascularized composite allotransplantation: a member of the transplant family? Transplantation 2012; 93:1088-1091.
20. Cendales LC, Rahmel A, Pruett TL. Allocation of vascularized composite allografts: what is it? Transplantation 2012; 93:1086-1087.
21. Ravindra K, Haeberle M, Levin LS, Ildstad ST. Immunology of vascularized composite allotransplantation: a primer for hand surgeons. J Hand Surg Am 2012; 37:842-850.
22. Starzl TE, Zinkernagel R. Antigen localization and migration in immunity and tolerance. N Engl J Med 1998; 339:1905-1913.
23. Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003; 361:1502-1510.
24. Starzl TE, Zinkernagel R. Transplantation tolerance from a historical perspective. Nat Rev Immunol 2001; 1:233-239.
25. Starzl TE. Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res 2007; 38:6-41.
26. Fontes P, Rao AS, Demetris AJ, et al. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 1994; 344:151-155.
27. Ciancio G, Miller J, Garcia-Morales RO, et al. Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation 2001; 71:827-835.
28. Hettiaratchy S, Melendy E, Randolph MA, et al. Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine. Transplantation 2004; 77:514-521.
29. Gorantla VS, Schneeberger S, Moore LR, et al. Development and validation of a procedure to isolate viable bone marrow cells from the vertebrae of cadaveric organ donors for composite organ grafting. Cytotherapy 2012; 1:104-113.
30. Schneeberger S, Gorantla VS, Brandacher G, et al. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg 2013; 257:345-351.
31. Leonard DA, Cetrulo CL Jr, McGrouther DA, Sachs DH. Induction of tolerance of vascularized composite allografts. Transplantation 2013; 95:403-409.
32. Breidenbach WC. Louisville Hand Transplant Program Update. American Society of Reconstructive Microsurgery Annual Meeting. 2010.
33. Ravindra KV, Xu H, Bozulic LD, et al. The need for inducing tolerance in vascularized composite allotransplantation. Clin Dev Immunol 2012; 2012:438078.
34. Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008; 358:362-368.
35. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358:353-361.
36. Leventhal J, Abecassis M, Miller J, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med 2012; 4:4124ra28.
37. Lin JY, Tsai FC, Wallace CG, et al. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation. J Surg Res 2012; 178:487-493.
38. Carty MJ, Zuker R, Cavadas P, et al. The case for lower extremity allotransplantation. Plast Reconstr Surg 2013; 131:1272-1277.
39. Kremer T, Giessler GA, Friedrich PF, et al. Surgical angiogenesis with shortterm immunosuppression maintains bone viability in rabbit allogenic knee joint transplantation. Plast Reconstr Surg 2013; 131:148e-157e.
40. Bojovic B, Dorafshar AH, Brown EN, et al. Total face, double jaw, and tongue transplant research procurement: an educational model. Plast Reconstr Surg 2012; 130:824-834.
41. Delaere PR, Vranckx JJ, Meulemans J, et al. Learning curve in tracheal allotransplantation. Am J Transplant 2012; 12:2538-2545.
42. Cavadas PC, Thione A, Carballeira A, Blanes M. Bilateral transfemoral lower extremity transplantation: result at 1 year. Am J Transplant 2013; 13:1343-1349.
43. Schnider JT, Weinstock M, Plock JA, et al. Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potential. Clin Dev Immunol 2013; 2013:495212.
44. Hautz T, Zelger B, Grahammer J, et al. Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. Am J Transplant 2010; 10:1200-1209.
45. Hautz T, Krapf C, Grahammer J, et al. Targeting the Kv1.3 potassium channel for immunosuppression in vascularized composite allotransplantation - a pilot study. Transpl Int 2013; 26:552-561.
46. Gharb BB, Rampazzo A, Altuntas SH, et al. Effectiveness of topical immunosuppressants in prevention and treatment of rejection in face allotransplantation. Transplantation 2013; 95:1197-1203.
47. Hautz T, Zelger BG, Weissenbacher A, et al. Standardizing skin biopsy sampling to assess rejection in vascularized composite allotransplantation. Clin Transplant 2013; 27:E81-E90.
48. Starzl R, Brandacher G, Lee WP, et al. Review of the early diagnoses and assessment of rejection in vascularized composite allotransplantation. Clin Dev Immunol 2013; 2013:402980.
49. Loupy A, Hill GS, Jordan SC. The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol 2012; 8:348-357.
50. Mundinger GS, Munivenkatappa R, Drachenberg CB, et al. Histopathology of chronic rejection in a nonhuman primate model of vascularized composite allotransplantation. Transplantation 2013; 95:1204-1210.
51. Lim WH, Clayton P, Wong G, et al. Outcomes of kidney transplantation from older living donors. Transplantation 2013; 95:106-113.
52. Unadkat JV, Bourbeau D, Afrooz PN, et al. Functional outcomes following multiple acute rejections in experimental vascularized composite allotransplantation. Plast Recontr Surg 2013; 131:720e-730e.
53. Sucher R, Lin CH, Oberhuber R, et al. Hemiface allotransplantation in the mouse. Plast Reconstr Surg 2012; 129:867-870.
54. Pomahac B, Becker YT, Cendales L, et al. Vascularized composite allotransplantation research: the emerging field. Am J Transplant 2012; 12:1062-1063.